FDA Approves BRIVARACETAM ORAL SOLUTION — Florida Pharmaceutical Products, LLC

# FDA Approves Generic Brivaracetam Oral Solution by Florida Pharmaceutical Products Florida Pharmaceutical Products, LLC has received FDA approval for a generic version of brivaracetam oral solution (ANDA220385), potentially expanding access to this anti-epileptic medication and intensifying price competition in the seizure disorder treatment market. The approval could significantly erode branded brivaracetam sales while offering patients and payers a more cost-effective alternative for managing partial-onset seizures.